Blue-blocking IOLs Decrease Photoreception Without Providing Significant Photoprotection

Survey of Ophthalmology

Volumn 55, Issue 3, 2010, Pages 272-283

  Mainster, Martin A ^a   Turner, Patricia L ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Blue light; Cell culture; Circadian photoreception; Intraocular lens; Macular degeneration; Melanoma; Melanopsin; Melatonin; Photic retinopathy; Photocarcinogenicity; Phototoxicity; Retina

Indexed keywords

ARTICLE; BLUE LIGHT; CARCINOGENICITY; CATARACT EXTRACTION; CIRCADIAN RHYTHM; CONTRAST SENSITIVITY; EYE PROTECTION; HUMAN; LENS IMPLANT; LENS IMPLANTATION; LUMINANCE; MESOPIC VISION; NIGHT VISION; PHOTOPIC VISION; PHOTOTOXICITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PSEUDOPHAKIA; RETINA MACULA AGE RELATED DEGENERATION; THERAPY EFFECT; ULTRAVIOLET B RADIATION; UVEA MELANOMA;

CIRCADIAN RHYTHM; COLOR VISION; CONTRAST SENSITIVITY; GLARE; HUMANS; LENSES, INTRAOCULAR; LIGHT; PHOTORECEPTOR CELLS, VERTEBRATE; PSEUDOPHAKIA; RADIATION PROTECTION;

EID: 77951456421     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2009.07.006     Document Type: Article

References (147)

1. Threshold limit values and biological exposure indices 2000, ACGIH, American Conference of Governmental Industrial Hygienists, Cincinnati, OH.
2. Arnarsson A., Sverrisson T., Stefansson E., et al. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Am J Ophthalmol 2006, 142:419-428.
3. Asplund R., Ejdervik Lindblad B. The development of sleep in persons undergoing cataract surgery. Arch Gerontol Geriatr 2002, 35:179-187.
4. Asplund R., Lindblad B.E. Sleep and sleepiness 1 and 9 months after cataract surgery. Arch Gerontol Geriatr 2004, 38:69-75.
5. Augustin A.J. The physiology of scotopic vision, contrast vision, color vision and circadian rhythmicity: can these parameters be influenced by blue-light-filter lenses?. Retina 2008, 28(9):1179-1187.
6. Baatz H., Darawsha R., Ackermann H., et al. Phacoemulsification does not induce neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2008, 49:1079-1083.
7. Barker F.M., Brainard G.C. The Direct Spectral Transmittance of the Excised Human Lens as a Function of Age (FDA 785345 0090 RA) 1991, U.S. Food and Drug Administration, Washington, DC.
8. Behndig A., Monestam E. Quantification of glistenings in intraocular lenses using Scheimpflug photography. J Cataract Refract Surg 2009, 35:14-17.
9. Berson D.M., Dunn F.A., Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002, 295:1070-1073.
10. Berson E.L. Light deprivation and retinitis pigmentosa. Vision Res 1980, 20:1179-1184.
11. Boettner E.A., Wolter J.R. Transmission of the ocular media. Invest Ophthalmol 1962, 1:776-783.
12. Boulton M., Rozanowska M., Rozanowski B. Retinal photodamage. J Photochem Photobiol B 2001, 64:144-161.
13. Brainard G.C., Hanifin J.P., Greeson J.M., et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 2001, 21:6405-6412.
14. Braunstein R.E., Sparrow J.R. A blue-blocking intraocular lens should be used in cataract surgery. Arch Ophthalmol 2005, 123:547-549.
15. Cajochen C., Munch M., Kobialka S., et al. High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab 2005, 90:1311-1316.
16. Campbell S.S., Kripke D.F., Gillin J.C., et al. Exposure to light in healthy elderly subjects and Alzheimer's patients. Physiol Behav 1988, 42:141-144.
17. Carson D., Margrain T.H., Patel A. Reply: Retinal photoxicity in the aging pseudophakic and phakic eye. J Cataract Refract Surg 2009, 35:210-211.
18. Medicare program: disapproval of adjustment in payment amounts for new technology intraocular lenses furnished by ambulatory surgical centers. Federal Register 2005, 70:15337-15340. Centers for Medicare & Medicaid Services.
19. Charman W.N. Age, lens transmittance, and the possible effects of light on melatonin suppression. Ophthalmic Physiol Opt 2003, 23:181-187.
20. Chew E.Y., Sperduto R.D., Milton R.C., et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-related Eye Disease Study: AREDS report 25. Ophthalmology 2009, 116:297-303.
21. Clemons T.E., Milton R.C., Klein R., et al. Risk factors for the incidence of Advanced Age-related Macular Degeneration in the Age-related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 2005, 112:533-539.
22. Curcio C.A., Millican C.L., Allen K.A., et al. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci 1993, 34:3278-3296.
23. Darzins P., Mitchell P., Heller R.F. Sun exposure and age-related macular degeneration. An Australian case-control study. Ophthalmology 1997, 104:770-776.
24. De Fabo E.C. Initial studies on an in vivo action spectrum for melanoma induction. Prog Biophys Mol Biol 2006, 92:97-104.
25. Delcourt C., Carriere I., Ponton-Sanchez A., et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study. Arch Ophthalmol 2001, 119:1463-1468.
26. Di Cesare S., Maloney S., Fernandes B.F., et al. The effect of blue light exposure in an ocular melanoma animal model. J Exp Clin Cancer Res 2009, 28:48.
27. Dickinson C.M. Optical aids for low vision. Visual Optics and Instrumentation 1991, 183-228. CRC Press, Inc, Boca Raton, FL. W.N. Charman (Ed.).
28. Dijk D.J., Neri D.F., Wyatt J.K., et al. Sleep, performance, circadian rhythms, and light-dark cycles during two space shuttle flights. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1647-R1664.
29. Edwards L., Torcellini P. A Literature Review of the Effects of Natural Light on Building Occupants 2002, National Renewable Energy Laboratory, U.S. Department of Energy, Golden, CO.
30. Enk C.D., Jacob-Hirsch J., Gal H., et al. The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene 2006, 25:2601-2614.
31. Evans J.R., Fletcher A.E., Wormald R.P. 28,000 cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 2005, 89:550-553.
32. Figueiro M.G., Rea M.S., Bullough J.D. Does architectural lighting contribute to breast cancer?. J Carcinog 2006, 5:20.
33. Fletcher A.E., Bentham G.C., Agnew M., et al. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol 2008, 126:1396-1403.
34. Gilchrest B.A., Eller M.S., Geller A.C., et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999, 340:1341-1348.
35. Golden R.N., Gaynes B.N., Ekstrom R.D., et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005, 162:656-662.
36. Griswold M.S., Stark W.S. Scotopic spectral sensitivity of phakic and aphakic observers extending into the near ultraviolet. Vision Res 1992, 32:1739-1743.
37. Gronfier C., Wright K.P., Kronauer R.E., et al. Entrainment of the human circadian pacemaker to longer-than-24-h days. Proc Natl Acad Sci USA 2007, 104:9081-9086.
38. Guenel P., Laforest L., Cyr D., et al. Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control 2001, 12:451-459.
39. Ham W.T., Mueller H.A., Ruffolo J.J., et al. Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. Am J Ophthalmol 1982, 93:299-306.
40. Hanifin J.P., Brainard G.C. Photoreception for circadian, neuroendocrine, and neurobehavioral regulation. J Physiol Anthropol 2007, 26:87-94.
41. Hankins M.W., Peirson S.N., Foster R.G. Melanopsin: an exciting photopigment. Trends Neurosci 2008, 31:27-36.
42. Hannibal J., Fahrenkrug J. Neuronal input pathways to the brain's biological clock and their functional significance. Adv Anat Embryol Cell Biol 2006, 182:1-71.
43. Hayashi K., Hayashi H. Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non-tinted intraocular lenses. Br J Ophthalmol 2006, 90:1019-1023.
44. Herljevic M., Middleton B., Thapan K., et al. Light-induced melatonin suppression: age-related reduction in response to short wavelength light. Exp Gerontol 2005, 40:237-242.
45. Hirvela H., Luukinen H., Laara E., et al. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996, 103:871-877.
46. Hyman L.G., Lilienfeld A.M., Ferris F.L., et al. Senile macular degeneration: a case-control study. Am J Epidemiol 1983, 118:213-227.
47. Jackson G.R., Owsley C., Cordle E.P., et al. Aging and scotopic sensitivity. Vision Res 1998, 38:3655-3662.
48. Jackson G.R., Owsley C., McGwin G. Aging and dark adaptation. Vision Res 1999, 39:3975-3982.
49. Jackson G.R., Owsley C. Scotopic sensitivity during adulthood. Vision Res 2000, 40:2467-2473.
50. Jackson G.R. Pilot study on the effect of a blue-light-blocking IOL on rod-mediated (scotopic) vision: American Society for Cataract and Refractive Surgery. Washington DC, 2005 Annual Meeting April 15-20, 2005.
51. Jahn C., Wustemeyer H., Brinkmann C., et al. Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol 2005, 243:222-227.
52. Jasser S.A., Hanifin J.P., Rollag M.D., et al. Dim light adaptation attenuates acute melatonin suppression in humans. J Biol Rhythms 2006, 21:394-404.
53. Kanis M.J., Wisse R.P., Berendschot T.T., et al. Foveal cone-photoreceptor integrity in aging macula disorder. Invest Ophthalmol Vis Sci 2008, 49:2077-2081.
54. Keep P.J. Stimulus deprivation in windowless rooms. Anaesthesia 1977, 32:598-602.
55. Khan J.C., Shahid H., Thurlby D.A., et al. Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br J Ophthalmol 2006, 90:29-32.
56. Knight J.A., Thompson S., Raboud J.M., et al. Light and exercise and melatonin production in women. Am J Epidemiol 2005, 162:1114-1122.
57. Lack L., Wright H. Shorter wavelength light is more effective for changing melatonin phase. Chronobiol Int 2003, 20:1179-1181.
58. Lamb L.E., Simon J.D. A2E: a component of ocular lipofuscin. Photochem Photobiol 2004, 79:127-136.
59. Landers J.A., Tamblyn D., Perriam D. Effect of a blue-light-blocking intraocular lens on the quality of sleep. J Cataract Refract Surg 2009, 35:83-88.
60. Lee H. Introduction to Color Imaging Science 2005, Cambridge University Press, Cambridge.
61. Lee T.M., Chan C.C., Paterson J.G., et al. Spectral properties of phototherapy for seasonal affective disorder: a meta-analysis. Acta Psychiatr Scand 1997, 96:117-121.
62. Lehrl S., Gerstmeyer K., Jacob J.H., et al. Blue light improves cognitive performance. J Neural Transm 2007, 114:457-460.
63. Lewy A.J., Emens J.S., Lefler B.J., et al. Melatonin entrains free-running blind people according to a physiological dose-response curve. Chronobiol Int 2005, 22:1093-1106.
64. Lockley S.W., Skene D.J., Tabandeh H., et al. Relationship between napping and melatonin in the blind. J Biol Rhythms 1997, 12:16-25.
65. Lockley S.W., Evans E.E., Scheer F.A., et al. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep 2006, 29:161-168.
66. Lubkin V., Beizai P., Sadun A.A. The eye as metronome of the body. Surv Ophthalmol 2002, 47:17-26.
67. Mainster M.A. Solar retinitis, photic maculopathy and the pseudophakic eye. J Am Intraocul Implant Soc 1978, 4:84-86.
68. Mainster M.A. Spectral transmittance of intraocular lenses and retinal damage from intense light sources. Am J Ophthalmol 1978, 85:167-170.
69. Mainster M.A., Ham W.T., Delori F.C. Potential retinal hazards. Instrument and environmental light sources. Ophthalmology 1983, 90:927-932.
70. Mainster M.A. The spectra, classification, and rationale of ultraviolet-protective intraocular lenses. Am J Ophthalmol 1986, 102:727-732.
71. Mainster M.A. Light and macular degeneration: a biophysical and clinical perspective. Eye 1987, 1:304-310.
72. Mainster M.A., Sparrow J.R. How much blue light should an IOL transmit?. Br J Ophthalmol 2003, 87:1523-1529.
73. Mainster M.A. Intraocular lenses should block UV radiation and violet but not blue light. Arch Ophthalmol 2005, 123:550-555.
74. Mainster M.A. Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol 2006, 90:784-792.
75. Mainster M.A. Blue-blocking intraocular lenses and pseudophakic scotopic sensitivity. J Cataract Refract Surg 2006, 32:1403-1404.
76. Mainster M.A., Boulton M. Retinal phototoxicity. Principles and Practice of Ophthalmology 2008, 2195-2205. Elsevier, London, UK. ed 3. D.M. Albert, J.W. Miller, B.A. Blodi, D.T. Azar (Eds.).
77. Mainster M.A., Turner P.L. Retinal phototoxicity in the aging pseudophakic and phakic eye. J Cataract Refract Surg 2009, 35:209-210.
78. Mainster M.A., Turner P.L. Blue-blocking intraocular lenses: myth or reality?. Am J Ophthalmol 2009, 147:8-10.
79. Mainster MA, Turner PL. Intraocular lens spectral filtering, in Steinert RF (ed). Cataract Surgery: Technique, Complications, and Management. London, UK, Saunders, ed 3, pp 477-86.
80. Mainster M.A., Turner P.L. Blue-blocking intraocular lenses: visual and nonvisual photoreception. Retina 2009, 29:417-420.
81. Margrain T.H., Boulton M., Marshall J., et al. Do blue light filters confer protection against age-related macular degeneration?. Prog Retin Eye Res 2004, 23:523-531.
82. Marmor M.F. Double fault! Ocular hazards of a tennis sunglass. Arch Ophthalmol 2001, 119:1064-1066.
83. Marshall J., Cionni R.J., Davison J., et al. Clinical results of the blue-light filtering AcrySof Natural foldable acrylic intraocular lens. J Cataract Refract Surg 2005, 31:2319-2323.
84. Marshall J.C., Gordon K.D., McCauley C.S., et al. The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines. Melanoma Res 2006, 16:537-541.
85. McCarty C.A., Mukesh B.N., Fu C.L., et al. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 2001, 119:1455-1462.
86. McIntyre I.M., Norman T.R., Burrows G.D., et al. Quantal melatonin suppression by exposure to low intensity light in man. Life Sci 1989, 45:327-332.
87. Mellerio J. Light effects on the retina. Principles and Practice of Ophthalmology 1994, vol. 1:1326-1345. Saunders Company, Philadelphia, PA, W.B. D.M. Albert, F.A. Jakobiec (Eds.).
88. Middleton B., Stone B.M., Arendt J. Human circadian phase in 12:12 h, 200: <8 lux and 1000: <8 lux light-dark cycles, without scheduled sleep or activity. Neurosci Lett 2002, 329:41-44.
89. Miles L.E., Raynal D.M., Wilson M.A. Blind man living in normal society has circadian rhythms of 24.9 hours. Science 1977, 198:421-423.
90. Mills P.R., Tomkins S.C., Schlangen L.J. The effect of high correlated colour temperature office lighting on employee well-being and work performance. J Circadian Rhythms 2007, 5:2.
91. Mishima K., Okawa M., Shimizu T., et al. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J Clin Endocrinol Metab 2001, 86:129-134.
92. Mukae H., Sato M. The effect of color temperature of lighting sources on the autonomic nervous functions. Ann Physiol Anthropol 1992, 11:533-538.
93. Nguyen-Tri D., Overbury O., Faubert J. The role of lenticular senescence in age-related color vision changes. Invest Ophthalmol Vis Sci 2003, 44:3698-3704.
94. Nilsson S.E. Are there advantages in implanting a yellow IOL to reduce the risk of AMD?. Acta Ophthalmol Scand 2004, 82:123-125.
95. Niwa K., Yoshino Y., Okuyama F., et al. Effects of tinted intraocular lens on contrast sensitivity. Ophthalmic Physiol Opt 1996, 16:297-302.
96. Nolan J.M., O'Reilly P., Loughman J., et al. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery. Invest Ophthalmol Vis 2009, 50:4777-4785.
97. Ohara M., Kawashima Y., Katoh O., et al. Blue light inhibits the growth of B16 melanoma cells. Jpn J Cancer Res 2002, 93:551-558.
98. Ohara M., Kawashima Y., Watanabe H., et al. Effects of blue-light-exposure on growth of extracorporeally circulated leukemic cells in rats with leukemia induced by 1-ethyl-1-nitrosourea. Int J Mol Med 2002, 10:407-411.
99. Olson M.D., Miller K.M. Implanting a clear intraocular lens in one eye and a yellow lens in the other eye: a case series. Am J Ophthalmol 2006, 141:957-958.
100. Pandita D., Raj S.M., Vasavada V.A., et al. Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. J Cataract Refract Surg 2007, 33:603-610.
101. Partonen T., Lonnqvist J. Bright light improves vitality and alleviates distress in healthy people. J Affect Disord 2000, 57:55-61.
102. Patel A.S., Dacey D.M. Relative effectiveness of a blue light-filtering intraocular lens for photoentrainment of the circadian rhythm. J Cataract Refract Surg 2009, 35:529-539.
103. Perreau-Lenz S., Kalsbeek A., Garidou M.L., et al. Suprachiasmatic control of melatonin synthesis in rats: inhibitory and stimulatory mechanisms. Eur J Neurosci 2003, 17:221-228.
104. Phipps-Nelson J., Redman J.R., Dijk D.J., et al. Daytime exposure to bright light, as compared to dim light, decreases sleepiness and improves psychomotor vigilance performance. Sleep 2003, 26:695-700.
105. Pierre A., Wittich W., Faubert J., et al. Luminance contrast with clear and yellow-tinted intraocular lenses. J Cataract Refract Surg 2007, 33:1248-1252.
106. Rea M.S., Figueiro M.G., Bullough J.D., et al. A model of phototransduction by the human circadian system. Brain Res Brain Res Rev 2005, 50:213-228.
107. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-control Study Group. Arch Ophthalmol 1992, 110:1701-1708.
108. Rosen E.S. A l'oeil malade la lumiere nuit. J Cataract Refract Surg 2005, 31:2237-2238.
109. Rozanowska M., Jarvis-Evans J., Korytowski W., et al. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 1995, 270:18825-18830.
110. Schefrin B.E., Tregear S.J., Harvey L.O., et al. Senescent changes in scotopic contrast sensitivity. Vision Res 1999, 39:3728-3736.
111. Schmidt-Pokrzywniak A., Stang A., Bornfeld N., et al. Risk of uveal melanoma. Ophthalmology 2007, 114:1418.
112. Schwiegerling J. Blue-light-absorbing lenses and their effect on scotopic vision. J Cataract Refract Surg 2006, 32:141-144.
113. Scilley K., Jackson G.R., Cideciyan A.V., et al. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology 2002, 109:1235-1242.
114. Shah C.P., Weis E., Lajous M., et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology 2005, 112:1599-1607.
115. Shah C.P., Weis E., Lajous M., et al. Blue light exposure and uveal melanoma. Ophthalmology 2006, 113:1062.
116. Singh A.D., Rennie I.G., Seregard S., et al. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 2004, 49:419-428.
117. Singh A.D., Bergman L., Seregard S. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am 2005, 18:75-84.
118. Skene D.J., Lockley S.W., Thapan K., et al. Effects of light on human circadian rhythms. Reprod Nutr Dev 1999, 39:295-304.
119. Sletten T.L., Revell V.L., Middleton B., et al. Age-related changes in acute and phase-advancing responses to monochromatic light. J Biol Rhythms 2009, 24:73-84.
120. Sliney D.H., Wolbarsht M.L. Safety with Lasers and Other Optical Sources: A Comprehensive Handbook 1980, Plenum Press, New York.
121. Sparrow J., Miller A.S., Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg 2004, 30:873-878.
122. Sparrow J.R., Nakanishi K., Parish C.A. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 2000, 41:1981-1989.
123. St Hilaire M.A., Gronfier C., Zeitzer J.M., et al. A physiologically based mathematical model of melatonin including ocular light suppression and interactions with the circadian pacemaker. J Pineal Res 2007, 43:294-304.
124. Stark W.S. Photopic sensitivities to ultraviolet and visible wavelengths and the effects of the macular pigments in human aphakic observers. Curr Eye Res 1987, 6:631-638.
125. Steen R., Whitaker D., Elliott D.B., Wi, et al. Effect of filters on disability glare. Ophthalmic Physiol Opt 1993, 13:371-376.
126. Stockman A., Sharpe L.T., Merbs S., et al. Spectral sensitivities of human cone visual pigments determined in vivo and in vitro. Methods Enzymol 2000, 316:626-650.
127. Sturr J.F., Zhang L., Taub H.A., et al. Psychophysical evidence for losses in rod sensitivity in the aging visual system. Vision Res 1997, 37:475-481.
128. Sutter F.K., Menghini M., Barthelmes D., et al. Is pseudophakia a risk factor for neovascular age-related macular degeneration?. Invest Ophthalmol Vis Sci 2007, 48:1472-1475.
129. Taylor H.R., West S., Munoz B., et al. The long-term effects of visible light on the eye. Arch Ophthalmol 1992, 110:99-104.
130. Thapan K., Arendt J., Skene D.J. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol 2001, 535:261-267.
131. Tomany S.C., Cruickshanks K.J., Klein R., et al. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2004, 122:750-757.
132. Ts'o M.O., La Piana F.G., Appleton B. The human fovea after sungazing. Trans Am Acad Ophthalmol Otolaryngol 1974, 78. OP677.
133. Turner P.L., Mainster M.A. Circadian photoreception: ageing and the eye's important role in systemic health. Br J Ophthalmol 2008, 92:1439-1444.
134. van de Kraats J., van Norren D. Sharp cutoff filters in intraocular lenses optimize the balance between light reception and light protection. J Cataract Refract Surg 2007, 33:879-887.
135. Van Gelder R.N. Non-visual photoreception: sensing light without sight. Curr Biol 2008, 18:R38-R39.
136. Vandewalle G., Gais S., Schabus M., et al. Wavelength-dependent modulation of brain responses to a working memory task by daytime light exposure. Cereb Cortex 2007, 17:2788-2795.
137. Wald G., Brown P.K. Human rhodopsin. Science 1958, 127:222-226.
138. Weale R.A. Guest editorial: notes on the macular pigment. Ophthalmic Physiol Opt 2007, 27:1-10.
139. Werner J.S. Night vision in the elderly: consequences for seeing through a " blue filtering" intraocular lens. Br J Ophthalmol 2005, 89:1518-1521.
140. Westheimer G. The Maxwellian view. Vision Res 1966, 6:669-682.
141. Wirtitsch M.G., Schmidinger G., Prskavec M., et al. Influence of blue-light-filtering intraocular lenses on color perception and contrast acuity. Ophthalmology 2009, 116:39-45.
142. Xu L., Li Y., Zheng Y., et al. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br J Ophthalmol 2006, 90:1087-1090.
143. Yang H.C., Chung S.K., Baek N.H. Decentration, tilt, and near vision of the array multifocal intraocular lens. J Cataract Refract Surg 2000, 26:586-589.
144. Yang Y., Thompson K., Burns S.A. Pupil location under mesopic, photopic, and pharmacologically dilated conditions. Invest Ophthalmol Vis Sci 2002, 43:2508-2512.
145. Yannuzzi L.A., Fisher Y.L., Slakter J.S., et al. Solar retinopathy. A photobiologic and geophysical analysis. Retina 1989, 9:28-43.
146. Zaidi M.R., Day C.P., Merlino G. From UVs to metastases: modeling melanoma initiation and progression in the mouse. J Invest Dermatol 2008, 128:2381-2391.
147. Zhao H., Mainster M.A. The effect of chromatic dispersion on pseudophakic optical performance. Br J Ophthalmol 2007, 91:1225-1229.